Cytomorphologic Spectrum of SMARCB1-Deficient Soft Tissue Neoplasms. [PDF]
Am J Clin Pathol, 2021 Abstract Objectives The SWI/SNF complex core subunit SMARCB1 is inactivated in a variety of neoplasms that share characteristic “rhabdoid” cytomorphology. The aim of this study was to evaluate SMARCB1-deficient soft tissue neoplasms on cytology to identify diagnostic clues.
Schaefer IM, Al-Ibraheemi A, Qian X.
europepmc +6 more sources
Clinicopathological Study of Soft Tissue Neoplasms [PDF]
CureusBackground Soft tissue neoplasm is a broad term referring to tumors that can arise from various tissues, including muscle, tendons, fat, nerves, and lymphatic and blood vessels. These neoplasms may be either benign or malignant, with classification based on the tissue of origin and tumor behavior.
Paul A, Mane S, Swami S, Gore A.
europepmc +3 more sources
SWI/SNF complex-deficient soft tissue neoplasms: An update. [PDF]
Semin Diagn Pathol, 2021 The SWItch Sucrose Non-Fermentable (SWI/SNF) chromatin remodeling complex is a large multi-subunit protein assembly that orchestrates chromatin compaction and accessibility for gene transcription in an ATP-dependent manner. As a key epigenetic regulator,
Schaefer IM, Hornick JL.
europepmc +2 more sources
A Case Series of Myopericytoma: A Soft Tissue Neoplasm [PDF]
NATIONAL JOURNAL OF LABORATORY MEDICINEMyopericytoma (MPC) is a rare benign mesenchymal neoplasm with perivascular myoid differentiation that most commonly arises in middle adulthood. The lesion generally involves the subcutaneous soft tissue of the lower extremities. Histologically, it is characterised by concentric perivascular proliferation of spindled myoid cells with bland elongated ...
Nupur Kaushik +3 more
openalex +3 more sources
Application of Immunohistochemistry to Soft Tissue Neoplasms
Archives of Pathology & Laboratory Medicine, 2008 AbstractContext.—Soft tissue tumors are composed of numerous and complex diagnostic entities. Because of this complexity and the recognition of an intermediate malignancy category including some tumors with a deceptively bland histologic appearance, soft tissue tumors may represent a major diagnostic challenge to the general practicing pathologist ...
Sophia Yohe, Josefine Heim-Hall
openaire +4 more sources
Radionuclide imaging of soft tissue neoplasms
Seminars in Nuclear Medicine, 1981 Two classes of radiopharmaceuticals may be used for imaging tumors of the musculoskeletal system. The first is comprised of soft tissue or tumor specific agents such as gallium-67, bleomycin, and radionuclide-labeled antibodies, which may be useful for detecting and localizing these tumors.
Department of Radiology, University of Florida Medical Center, Gainesville, Fla., USA ( host institution ) +3 more
openaire +5 more sources
Molecular Pathology of Soft-Tissue Neoplasms and Its Role in Clinical Practice [PDF]
Cancer Control: Journal of the Moffitt Cancer Cente, 2015 Evita Henderson‐Jackson +1 more
openalex +2 more sources
PDGFRA::USP8 Fusion in a Cutaneous Inflammatory Myofibroblastic Tumor, Highlighting Genetic Pleiotropy of Kinase Gene Fusions in Soft Tissue Neoplasms. [PDF]
Genes Chromosomes CancerVernemmen AIP +6 more
europepmc +2 more sources
Machine Learning in the Differentiation of Soft Tissue Neoplasms: Comparison of Fat-Suppressed T2WI and Apparent Diffusion Coefficient (ADC) Features-Based Models. [PDF]
J Digit Imaging, 2021 Hu P, Chen L, Zhou Z.
europepmc +3 more sources
Proceedings of the North American Society of Head and Neck Pathology, Los Angeles, CA, March 20, 2022. Emerging Bone and Soft Tissue Neoplasms in the Head and Neck Region. [PDF]
Head Neck Pathol, 2022 Xu B.
europepmc +3 more sources